HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

DIAGENS-B

474.600

+24.6005.47%

Volume:200.55K

Turnover:94.15M

Market Cap:42.18B

PE:-565.66

High:500.000

Open:450.000

Low:421.000

Close:450.000

52wk High:765.500

52wk Low:178.000

Shares:88.88M

HK Float Shares:88.88M

Volume Ratio:1.35

T/O Rate:0.23%

Dividend:- -

Dividend Rate:- -

EPS(LYR):-0.839

ROE:-39.50%

ROA:-23.53%

PB:46.55

PE(LYR):-565.66

PS:196.82

Loading ...

Overview Company News Filings

Diagens Annual Results: 100B-Parameter Model Reshapes Medical AI Landscape; Licensing Revenue Becomes Primary Growth Engine

THOMSON REUTERS

杭州迪安剑生2025年年报聚焦AI医疗影像：营收达1.64424亿元，同比增长133.6%，技术授权收入首超八千万

Bulletin Express

Hangzhou Diagens publishes 2025 annual report

DIAGENS-B Moves to Update Articles of Association After IPO and Regulatory Changes

Bulletin Express

Hangzhou Diagens proposes share incentive scheme featuring RSUs and stock options

Hangzhou Diagens proposes articles of association amendments after Hong Kong listing

DIAGENS-B Proposes Implementation of Share Incentive Scheme

DIAGENS-B Showcases Medical Imaging Base Model Capable of Slashing AI Development Costs by Over 90%

DIAGENS-B March 2026 Monthly Return Shows Stable Share Base and Public Float Compliance

Bulletin Express

Stock Track | DIAGENS-B Soars 5.41% Intraday on Strong Q1 Earnings and AI Product Regulatory Progress

Diagens adopts full electronic dissemination of corporate communications

Bulletin Express

DIAGENS-B Shares Surge Over 7% Again, AI AutoVision Nears Approval as First Domestic AI-Powered Chromosome Analysis Diagnostic Tool

Stock Track | DIAGENS-B Soars 5.60% Intraday on Strong Q1 Earnings Beat

Stock Track | DIAGENS-B Soars 6.24% Intraday on Strong Q1 Earnings and Positive Market Sentiment

Large Model Concept Stocks Show Strong Performance Before Noon, with DIAGENS-B and KNOWLEDGE ATLAS Both Rising Over 15%

DIAGENS-B Shares Surge Over 7% on Strong AI Medical Imaging Foundation Model

Diagens Issues FY2025 Results Notice; Full Annual Report to be Released by 30 April 2026

Bulletin Express

Medical Imaging AI Pioneer DIAGENS-B Soars 121% in Hong Kong IPO Debut

Hangzhou Diagens Biotechnology Soars 121% in Hong Kong Trading Debut

MT Newswires Live

Stock Track | DIAGENS-B Soars 113.94% on Trading Debut as Medical Imaging AI Firm Opens at Significant Premium to IPO Price

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.imtigers.com/stock/02526/news?page=4"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"02526","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02526\",,,,,undefined,":{"symbol":"02526","market":"HK","secType":"STK","nameCN":"DIAGENS-B","latestPrice":474.6,"timestamp":1789114135003,"preClose":450,"halted":0,"volume":200545,"delay":0,"changeRate":0.05466666666666672,"floatShares":88879200,"shares":88879200,"eps":-0.839024,"marketStatus":"Not Yet Opened","change":24.6,"latestTime":"09-11 16:08:55","open":450,"high":500,"low":421,"amount":94148027,"amplitude":0.175556,"askPrice":474.6,"askSize":25900,"bidPrice":472,"bidSize":50,"shortable":3,"etf":0,"ttmEps":-1.576,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1789349400000},"marketStatusCode":0,"adr":0,"listingDate":1774800000000,"exchange":"SEHK","adjPreClose":450,"openAndCloseTimeList":[[1789090200000,1789099200000],[1789102800000,1789113600000]],"volumeRatio":1.346440219241385,"lotSize":50,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02526\",,,,,undefined,":{"symbol":"02526","floatShares":88879200,"roa":"-23.53%","roe":"-39.50%","lyrEps":-0.839024,"volumeRatio":1.346440219241385,"shares":88879200,"dividePrice":0,"high":500,"amplitude":0.175556,"preClose":450,"low":421,"week52Low":178,"pbRate":"46.55","psRate":"196.82","week52High":765.5,"institutionHeld":0,"latestPrice":474.6,"committee":-0.996146,"eps":-0.839024,"divideRate":0,"volume":200545,"delay":0,"ttmEps":-1.576,"open":450,"prevYearClose":99,"prevWeekClose":474.6,"prevMonthClose":529,"prevQuarterClose":309.8,"fiveDayClose":495.6,"twentyDayClose":370,"sixtyDayClose":318.4},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02526\",params:#limit:5,,,undefined,":[{"date":"2026-08-07","symbol":"02526","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1786066200000,"name":null,"time":"","dateTimestamp":1786032000000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02526\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02526\",market:\"HK\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02526\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02526","date":"2026-09-11","current":-301.142132,"percent":0.846847,"low":-545.299386,"twenty":-393.599512,"median":-347.715447,"eighty":-310.507806,"high":-208.205701,"avg":-352.148299,"sd":64.729024,"marketCap":42182068320},"quantilePoints":[{"date":"2026-04-02","current":-272.27881,"twenty":-277.682472,"median":-258.576907,"eighty":-239.167269,"marketCap":20797732800},{"date":"2026-04-10","current":-346.403686,"twenty":-339.232012,"median":-285.787965,"eighty":-250.355764,"marketCap":26663760000},{"date":"2026-04-17","current":-325.713634,"twenty":-334.091876,"median":-317.126763,"eighty":-274.980641,"marketCap":25081710240},{"date":"2026-04-24","current":-330.080861,"twenty":-335.567541,"median":-326.636989,"eighty":-290.709378,"marketCap":25419451200},{"date":"2026-04-30","current":-332.18176,"twenty":-334.015312,"median":-325.713634,"eighty":-310.395031,"marketCap":25597209600},{"date":"2026-05-08","current":-379.447849,"twenty":-346.403686,"median":-328.46508,"eighty":-310.958904,"marketCap":29330136000},{"date":"2026-05-15","current":-344.735778,"twenty":-356.513965,"median":-332.396872,"eighty":-313.054502,"marketCap":26717087520},{"date":"2026-05-22","current":-402.3084,"twenty":-358.871836,"median":-336.827112,"eighty":-315.164028,"marketCap":31107720000},{"date":"2026-05-29","current":-406.641648,"twenty":-379.946058,"median":-343.048303,"eighty":-318.304405,"marketCap":31552116000},{"date":"2026-06-05","current":-360.299962,"twenty":-379.450143,"median":-344.735778,"eighty":-319.954129,"marketCap":27996948000},{"date":"2026-06-12","current":-372.447501,"twenty":-375.674905,"median":-349.027955,"eighty":-324.604965,"marketCap":28921291680},{"date":"2026-06-18","current":-353.616435,"twenty":-376.618141,"median":-353.630358,"eighty":-326.267647,"marketCap":27517000320},{"date":"2026-06-26","current":-343.086832,"twenty":-373.551497,"median":-351.652224,"eighty":-326.764376,"marketCap":26574880800},{"date":"2026-07-03","current":-355.442852,"twenty":-372.637829,"median":-352.781753,"eighty":-328.141924,"marketCap":27552552000},{"date":"2026-07-10","current":-525.783409,"twenty":-380.947063,"median":-353.887402,"eighty":-330.921221,"marketCap":40706673600},{"date":"2026-07-17","current":-330.366333,"twenty":-387.12216,"median":-355.442852,"eighty":-331.092504,"marketCap":25668312960},{"date":"2026-07-24","current":-307.647435,"twenty":-382.392854,"median":-353.630358,"eighty":-326.721913,"marketCap":23908504800},{"date":"2026-07-31","current":-369.618431,"twenty":-381.442978,"median":-353.199094,"eighty":-325.898305,"marketCap":28779084960},{"date":"2026-08-07","current":-476.223264,"twenty":-396.494596,"median":-354.130521,"eighty":-326.679451,"marketCap":37151505600},{"date":"2026-08-14","current":-232.289361,"twenty":-400.612159,"median":-353.887402,"eighty":-323.520825,"marketCap":32885304000},{"date":"2026-08-21","current":-329.499393,"twenty":-396.494596,"median":-352.781753,"eighty":-318.122472,"marketCap":46750459200},{"date":"2026-08-28","current":-306.753265,"twenty":-400.612159,"median":-352.216988,"eighty":-315.707365,"marketCap":43533032160},{"date":"2026-09-04","current":-310.261155,"twenty":-396.494596,"median":-351.396357,"eighty":-315.297789,"marketCap":44048531520},{"date":"2026-09-11","current":-296.714079,"twenty":-393.599512,"median":-347.715447,"eighty":-310.507806,"marketCap":42182068320}],"updateTime":1789337095044},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02526\",pageSize:20,pageCount:4,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2631050503","title":"Diagens Annual Results: 100B-Parameter Model Reshapes Medical AI Landscape; Licensing Revenue Becomes Primary Growth Engine","url":"https://stock-news.laohu8.com/highlight/detail?id=2631050503","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631050503?lang=en_us&edition=fundamental","pubTime":"2026-04-30 13:05","pubTimestamp":1777525504,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260430:nTUA6ZPDJC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["02526","BK1100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1118483343","title":"杭州迪安剑生2025年年报聚焦AI医疗影像：营收达1.64424亿元，同比增长133.6%，技术授权收入首超八千万","url":"https://stock-news.laohu8.com/highlight/detail?id=1118483343","media":"Bulletin Express","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1118483343?lang=en_us&edition=fundamental","pubTime":"2026-04-29 23:30","pubTimestamp":1777476643,"startTime":"0","endTime":"0","summary":"杭州迪安剑生生物科技有限公司在本年度报告中披露，2025年度集团整体业务保持快速增长，营业收入达到人民币1.64424亿元（下同，金额均以“亿元”计，下同，数据来自原报告记载的“百万元”除以100换算），较2024年度的0.70352亿元同比增长约133.6%。毛利约为1.18087亿元，较上年同期的0.46061亿元增长超过一倍，毛利率升至71.8%。值得注意的是，技术授权收入约0.84300亿...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"杭州迪安剑生2025年年报聚焦AI医疗影像：营收达1.64424亿元，同比增长133.6%，技术授权收入首超八千万","news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02526"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631439945","title":"Hangzhou Diagens publishes 2025 annual report","url":"https://stock-news.laohu8.com/highlight/detail?id=2631439945","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631439945?lang=en_us&edition=fundamental","pubTime":"2026-04-29 22:30","pubTimestamp":1777473033,"startTime":"0","endTime":"0","summary":"Hangzhou Diagens Biotechnology annual report for year ended Dec. 31, 2025 flagged a shift from product-led sales toward platform-driven monetization, with technology licensing becoming largest revenue stream at RMB 84.34 million.Core chromosome karyotyping software AI AutoVision was designated a Class III Innovative Medical Device in May 2025, with China NMPA registration still under review and targeted for completion in Q2 2026.iMedImage foundation model scaled to 104 billion parameters, positioning business to expand beyond single-disease tools into broader medical imaging workflows.iMed MaaS platform launched March 31, 2025, with six-month rollout cited at 65 hospital partnerships and 92 imaging-focused models incubated.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as fina","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260429:nNDL1TGvcL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1100","02526"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1181077977","title":"DIAGENS-B Moves to Update Articles of Association After IPO and Regulatory Changes","url":"https://stock-news.laohu8.com/highlight/detail?id=1181077977","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1181077977?lang=en_us&edition=fundamental","pubTime":"2026-04-29 17:06","pubTimestamp":1777453603,"startTime":"0","endTime":"0","summary":"Hangzhou Diagens Biotechnology Co., Ltd. (DIAGENS-B) has announced a plan to revise its Articles of Association following two significant developments: the March 2025 update of the China Securities...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02526"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631981845","title":"Hangzhou Diagens proposes share incentive scheme featuring RSUs and stock options","url":"https://stock-news.laohu8.com/highlight/detail?id=2631981845","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631981845?lang=en_us&edition=fundamental","pubTime":"2026-04-29 17:01","pubTimestamp":1777453281,"startTime":"0","endTime":"0","summary":"Hangzhou Diagens Biotechnology proposed adoption of a share incentive scheme covering restricted share units and options.Board resolution dated April 29, 2026 set up shareholder vote at an AGM or EGM targeted for around June 2026.Awards would be settled using H shares bought in secondary market, newly issued H shares, or treasury shares.Company plans to publish a circular with meeting notice and scheme details.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Hangzhou Diagens Biotechnology Co. Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on April 29, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260429:nNDL3G234w:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02526","BK1100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631904598","title":"Hangzhou Diagens proposes articles of association amendments after Hong Kong listing","url":"https://stock-news.laohu8.com/highlight/detail?id=2631904598","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631904598?lang=en_us&edition=fundamental","pubTime":"2026-04-29 17:00","pubTimestamp":1777453243,"startTime":"0","endTime":"0","summary":"Hangzhou Diagens Biotechnology proposed amendments to its articles of association, following regulatory updates and its March 30, 2026 Main Board listing in Hong Kong.Changes aim to align governance documents with updated PRC rules issued in March 2025.Revisions also reflect a post-IPO share capital structure of 88,879,200 shares, all H shares.Amendments require shareholder approval via special resolution at upcoming annual general meeting.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Hangzhou Diagens Biotechnology Co. Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on April 29, 2026, and is solely responsible for the information ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260429:nNDL6FGGzP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1100","02526"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1129004203","title":"DIAGENS-B Proposes Implementation of Share Incentive Scheme","url":"https://stock-news.laohu8.com/highlight/detail?id=1129004203","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1129004203?lang=en_us&edition=fundamental","pubTime":"2026-04-29 16:52","pubTimestamp":1777452764,"startTime":"0","endTime":"0","summary":"DIAGENS-B (02526) has announced that its board of directors passed a resolution during a meeting held on April 29, 2026, recommending the adoption of a share incentive plan. The plan aims to foster...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02526","301122","BK0251","BK1100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1165416316","title":"DIAGENS-B Showcases Medical Imaging Base Model Capable of Slashing AI Development Costs by Over 90%","url":"https://stock-news.laohu8.com/highlight/detail?id=1165416316","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1165416316?lang=en_us&edition=fundamental","pubTime":"2026-04-22 20:31","pubTimestamp":1776861069,"startTime":"0","endTime":"0","summary":"At the recent 2026 10th Everything Grows Conference, Hangzhou DIAGENS Biotechnology Co., Ltd. presented its self-developed iMedImage® medical imaging base model in the \"Hangzhou AI 18 Arhats\" joint...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02251","02526","CHAT","AIPO","BK1100","AGIX","ARTY","BK1189"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1175371587","title":"DIAGENS-B March 2026 Monthly Return Shows Stable Share Base and Public Float Compliance","url":"https://stock-news.laohu8.com/highlight/detail?id=1175371587","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1175371587?lang=en_us&edition=fundamental","pubTime":"2026-04-22 17:08","pubTimestamp":1776848882,"startTime":"0","endTime":"0","summary":"Hangzhou Diagens Biotechnology Co., Ltd. (DIAGENS-B) filed a resubmitted monthly return with Hong Kong Exchanges and Clearing on 22 April 2026, covering the period to 31 March 2026—the company’s...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02526"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1139693430","title":"Stock Track | DIAGENS-B Soars 5.41% Intraday on Strong Q1 Earnings and AI Product Regulatory Progress","url":"https://stock-news.laohu8.com/highlight/detail?id=1139693430","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1139693430?lang=en_us&edition=fundamental","pubTime":"2026-04-22 10:01","pubTimestamp":1776823280,"startTime":"0","endTime":"0","summary":"DIAGENS-B's stock price surged 5.41% during intraday trading on Wednesday, extending its recent positive momentum in the market.The significant upward movement appears driven by a combination of...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["02526"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1187377963","title":"Diagens adopts full electronic dissemination of corporate communications","url":"https://stock-news.laohu8.com/highlight/detail?id=1187377963","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1187377963?lang=en_us&edition=fundamental","pubTime":"2026-04-20 16:43","pubTimestamp":1776674625,"startTime":"0","endTime":"0","summary":"Hangzhou Diagens Biotechnology Co., Ltd. (Diagens) announced that, in line with Rule 2.07 of the Hong Kong Stock Exchange Listing Rules and the paperless listing regime effective since 31 December...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02526"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1127375670","title":"DIAGENS-B Shares Surge Over 7% Again, AI AutoVision Nears Approval as First Domestic AI-Powered Chromosome Analysis Diagnostic Tool","url":"https://stock-news.laohu8.com/highlight/detail?id=1127375670","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1127375670?lang=en_us&edition=fundamental","pubTime":"2026-04-20 10:30","pubTimestamp":1776652234,"startTime":"0","endTime":"0","summary":"DIAGENS-B (02526) saw its shares rise more than 7% again. As of the time of writing, the stock was up 6.02%, trading at HKD 299.2 with a turnover of HKD 27.43 million. Public information indicates...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CHAT","BK4585","AGIX","BK1100","BK4588","ARTY","VGT","AIPO","VXUS","02526","159180"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1109878773","title":"Stock Track | DIAGENS-B Soars 5.60% Intraday on Strong Q1 Earnings Beat","url":"https://stock-news.laohu8.com/highlight/detail?id=1109878773","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1109878773?lang=en_us&edition=fundamental","pubTime":"2026-04-20 09:48","pubTimestamp":1776649710,"startTime":"0","endTime":"0","summary":"DIAGENS-B's stock surged 5.60% during intraday trading on Monday, reflecting strong investor confidence in the company's latest financial performance.The significant price increase was primarily...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["02526"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1153309491","title":"Stock Track | DIAGENS-B Soars 6.24% Intraday on Strong Q1 Earnings and Positive Market Sentiment","url":"https://stock-news.laohu8.com/highlight/detail?id=1153309491","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1153309491?lang=en_us&edition=fundamental","pubTime":"2026-04-16 11:59","pubTimestamp":1776311970,"startTime":"0","endTime":"0","summary":"DIAGENS-B's stock surged 6.24% during intraday trading on Thursday, reflecting significant investor interest.The sharp rise was primarily driven by the company's reported significant improvement in...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["02526"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1126584549","title":"Large Model Concept Stocks Show Strong Performance Before Noon, with DIAGENS-B and KNOWLEDGE ATLAS Both Rising Over 15%","url":"https://stock-news.laohu8.com/highlight/detail?id=1126584549","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1126584549?lang=en_us&edition=fundamental","pubTime":"2026-04-08 11:50","pubTimestamp":1775620218,"startTime":"0","endTime":"0","summary":"Large model concept stocks demonstrated robust performance in the morning session before noon. DIAGENS-B increased by 14.96%, reaching 269 HKD. KNOWLEDGE ATLAS rose by 14.63%, trading at 893 HKD. MiniMax advanced by 7.64%, with its price at 1022 HKD.","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1117","02526","02513"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1129482998","title":"DIAGENS-B Shares Surge Over 7% on Strong AI Medical Imaging Foundation Model","url":"https://stock-news.laohu8.com/highlight/detail?id=1129482998","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1129482998?lang=en_us&edition=fundamental","pubTime":"2026-04-08 09:54","pubTimestamp":1775613258,"startTime":"0","endTime":"0","summary":"Shares of DIAGENS-B (02526), known as the first listed company focused on medical imaging large models, rose more than 7% in morning trading. At the time of writing, the stock was up 6.84% to HK$250,...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1189","BK4588","02526","02251","AIPO","VXUS","CHAT","BK4585","ARTY","AGIX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1162374303","title":"Diagens Issues FY2025 Results Notice; Full Annual Report to be Released by 30 April 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=1162374303","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1162374303?lang=en_us&edition=fundamental","pubTime":"2026-03-31 20:05","pubTimestamp":1774958753,"startTime":"0","endTime":"0","summary":"Hangzhou Diagens Biotechnology Co., Ltd. (Diagens) has issued an announcement pursuant to the Note to Rule 13.49(1) of the Hong Kong Listing Rules regarding its financial results for the year ended...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02526"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"1120317325","title":"Medical Imaging AI Pioneer DIAGENS-B Soars 121% in Hong Kong IPO Debut","url":"https://stock-news.laohu8.com/highlight/detail?id=1120317325","media":"Deep News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1120317325?lang=en_us&edition=fundamental","pubTime":"2026-03-30 11:41","pubTimestamp":1774842103,"startTime":"0","endTime":"0","summary":"The Hong Kong stock market witnessed another milestone in the AI large model sector today. DIAGENS-B officially commenced trading on the Hong Kong Stock Exchange, with its shares priced at HKD 99...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02251","02526","BK1189"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2623364001","title":"Hangzhou Diagens Biotechnology Soars 121% in Hong Kong Trading Debut","url":"https://stock-news.laohu8.com/highlight/detail?id=2623364001","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623364001?lang=en_us&edition=fundamental","pubTime":"2026-03-30 09:46","pubTimestamp":1774835198,"startTime":"0","endTime":"0","summary":"Hangzhou Diagens Biotechnology's (HKG:2526) shares opened 121.2% above their initial public offering price in a stellar Hong Kong debut on Monday morning.The Chinese biotechnology company opened at HK$219.00 per share, compared with the offer price of HK$99.00.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["02526"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1162103240","title":"Stock Track | DIAGENS-B Soars 113.94% on Trading Debut as Medical Imaging AI Firm Opens at Significant Premium to IPO Price","url":"https://stock-news.laohu8.com/highlight/detail?id=1162103240","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1162103240?lang=en_us&edition=fundamental","pubTime":"2026-03-30 09:39","pubTimestamp":1774834756,"startTime":"0","endTime":"0","summary":"DIAGENS-B's stock soared 113.94% intraday on Monday as the biotechnology company made its trading debut on the Hong Kong Stock Exchange.The company's initial public offering was priced at HK$99 per...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["02526"],"isVideo":false,"video":null,"gpt_icon":1}],"pageSize":20,"totalPage":5,"pageCount":4,"totalSize":100,"code":"91000000","status":"200"}]}}